Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in Vitro. [PDF]
Neurotox Res, 2019 Zakrocka I +5 more
europepmc +1 more source
Effect of cyclooxygenase-2 inhibitors at therapeutic doses on body temperature during anesthesia in healthy dogs administered with amino acids. [PDF]
J Vet Med Sci, 2019 Takashima S +5 more
europepmc +1 more source
Antitumor Activity of Cytotoxic Cyclooxygenase-2 Inhibitors. [PDF]
ACS Chem Biol, 2016 Uddin MJ +7 more
europepmc +1 more source
Pooled analysis of the clinical benefit of cyclooxygenase-2 inhibitors combined with chemotherapy in advanced non-small cell lung cancer. [PDF]
Transl Cancer Res, 2019 Zheng W, Liao ZM, Fu Y, Wu YP, Zhang Q.
europepmc +1 more source
Cardiovascular effects of cyclooxygenase-2 inhibitors: a mechanistic and clinical perspective. [PDF]
Br J Clin Pharmacol, 2016 Patrono C.
europepmc +1 more source
Role of cyclooxygenase-2 inhibitors in the survival outcome of colorectal cancer patients: A population-based cohort study. [PDF]
Kaohsiung J Med Sci, 2017 Huang WW, Hsieh KP, Huang RY, Yang YH.
europepmc +1 more source
Structure-activity relationships for the synthesis of selective cyclooxygenase 2 inhibitors: an overview (2009-2016). [PDF]
Medchemcomm, 2017 Carullo G, Galligano F, Aiello F.
europepmc +1 more source
Propyphenazone-based analogues as prodrugs and selective cyclooxygenase-2 inhibitors. [PDF]
ACS Med Chem Lett, 2014 Radwan MF, Dalby KN, Kaoud TS.
europepmc +1 more source
Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications. [PDF]
Ther Adv Drug Saf, 2017 Fanelli A, Ghisi D, Aprile PL, Lapi F.
europepmc +1 more source
Comparison of benefit-risk preferences of patients and physicians regarding cyclooxygenase-2 inhibitors using discrete choice experiments. [PDF]
Patient Prefer Adherence, 2016 Byun JH +5 more
europepmc +1 more source